Not Signed In - New Data Examines TYGACIL (Tigecycline) In Patients With Community-Acquired Pneumonia
Sat, 30 Sep 2006 07:00 AM EST
... Wyeth Pharmaceuticals, a division of Wyeth (NYSE: WYE), presented data today from Phase III studies in patients with community-acquired pneumonia (CAP) at the 46th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) in San Francisco, California. Community-acquired pneumonia is defined as pneumonia not acquired in a hospital or long-term care facility. [click link for full article] ...
Related Topics
- Community Acquired Pneumonia
- Pneumonia
- Data & Statistics
- Data Analysis
- National Data
- Community Outreach
- Community Health
- Community Development
- Hospital-acquired pneumonia
- MRSA
- Tigecycline
- Mining
- Faith-Based and Community Initiatives
- Community and Faith-Based Initiatives
- Retirement
- Acquired Immune Deficiency Syndrome
- Seizures (in about half of patients)
- What Your Female Patients Want to Know About Bladder Control
- Vaccinations For HIV/AIDs Patients
- Smoking Cessation and Continued Risk in Cancer Patients
email this page
print this page
bookmark this page
feedback on this page
